QIAGEN (QGEN), Denovo to Develop CDx Test for Lymphoid Cancer

Published on December 10, 2021

QIAGEN (QGEN) will develop a diagnostic assay that can identify the Denovo Genomic Marker 1 in patients with lymphoid cancer.

Continue reading on website
Other news

How to Build a Business and a Family at the Same Time

December 10, 2021
The choice between work and life shouldn't be an accepted symptom of entrepreneurship.

Major U.S. Retailers Urge Congress to Help Amid Smash-and-Grab Crime Surge

December 10, 2021
The group asked Congress to pass legislation that would make it difficult for perpetrators to resell stolen merchandise online.